These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 39307909)

  • 1. Acquired hemophilia A as a disease of the elderly: A comprehensive review of epidemiology, pathogenesis, and novel therapy.
    Lehoczki A; Fekete M; Mikala G; Bodó I
    Geroscience; 2024 Sep; ():. PubMed ID: 39307909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International recommendations on the diagnosis and treatment of acquired hemophilia A.
    Tiede A; Collins P; Knoebl P; Teitel J; Kessler C; Shima M; Di Minno G; d'Oiron R; Salaj P; Jiménez-Yuste V; Huth-Kühne A; Giangrande P
    Haematologica; 2020 Jul; 105(7):1791-1801. PubMed ID: 32381574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should emicizumab be used in patients with acquired hemophilia A?
    Tiede A; Kemkes-Matthes B; Knöbl P
    J Thromb Haemost; 2021 Mar; 19(3):637-644. PubMed ID: 33306259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired Hemophilia A: An Update on the Etiopathogenesis, Diagnosis, and Treatment.
    Zanon E
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired Hemophilia A: Bleeding Pattern and Hemostatic Therapeutic Strategies.
    Marino R
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options.
    Shetty S; Bhave M; Ghosh K
    Autoimmun Rev; 2011 Apr; 10(6):311-6. PubMed ID: 21115138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emicizumab as first-line therapy in acquired hemophilia A.
    Iarossi M; Hermans C
    Res Pract Thromb Haemost; 2024 May; 8(4):102438. PubMed ID: 38953052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder.
    Sakurai Y; Takeda T
    J Immunol Res; 2014; 2014():320674. PubMed ID: 24741588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive evaluation of anti-emicizumab antibodies in acquired hemophilia A: a detailed case study and methodological evaluation.
    Pezeshkpoor B; Sereda N; Becker-Gotot J; Berkemeier AC; Matuschek I; Müller J; Ramaraje Urs SU; Singh S; Klein C; Marquardt N; Oldenburg J
    J Thromb Haemost; 2024 Oct; ():. PubMed ID: 39401737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emicizumab for the treatment of acquired hemophilia A.
    Knoebl P; Thaler J; Jilma P; Quehenberger P; Gleixner K; Sperr WR
    Blood; 2021 Jan; 137(3):410-419. PubMed ID: 32766881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case Report of Idiopathic Acquired Hemophilia Type A.
    Amu-Hernández LA; Marzo-Alonso C; Tugues-Peiró A; Vicente-Pascual EP; Monteagudo-Aguilar P
    Cureus; 2023 May; 15(5):e38634. PubMed ID: 37284359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic lupus erythematosus with acquired hemophilia A: a case report].
    Yang F; Zhou YS; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1108-1111. PubMed ID: 30562791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired hemophilia: a case report and review of the literature.
    Mulliez SM; Vantilborgh A; Devreese KM
    Int J Lab Hematol; 2014 Jun; 36(3):398-407. PubMed ID: 24750687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review.
    Sella C; Bardetta M; Valeri F; Dainese C; Valpreda A; Massaia M; Grimaldi D; Porreca A; Bruno B; Borchiellini A
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emicizumab Use in Treatment of Acquired Hemophilia A: A Case Report.
    Al-Banaa K; Alhillan A; Hawa F; Mahmood R; Zaki A; El Abdallah M; Zimmerman J; Musa F
    Am J Case Rep; 2019 Jul; 20():1046-1048. PubMed ID: 31318850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of emicizumab in acquired hemophilia A: A case report.
    Yates SG; Webb CB; Sarode R; Ibrahim IF; Shen YP
    Transfus Apher Sci; 2022 Dec; 61(6):103457. PubMed ID: 35643753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired Hemophilia A: A Permanent Challenge for All Physicians.
    Nowak KM; Carpinteiro A; Szalai C; Saner FH
    Medicines (Basel); 2022 Mar; 9(3):. PubMed ID: 35323720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired Hemophilia A: A Potentially Fatal Bleeding Disorder.
    Singh N; Singh Lubana S; Dabrowski L
    Cureus; 2020 Jun; 12(6):e8744. PubMed ID: 32714682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding.
    Pasca S; Zanon E; Mannucci PM; Peyvandi F
    Blood Transfus; 2023 Nov; 21(6):549-556. PubMed ID: 36795341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired haemophilia: Update in 2024].
    Lévesque H; Guillet B; d'Oiron R; Benhamou Y
    Rev Med Interne; 2024 Nov; 45(11):710-725. PubMed ID: 39245591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.